kabutan

TOWA PHARMACEUTICAL CO.,LTD.(4553) Summary

4553
TSE Prime
TOWA PHARMACEUTICAL CO.,LTD.
4,405
JPY
+70
(+1.61%)
Apr 16, 3:30 pm JST
27.72
USD
Apr 16, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
12.2
PBR
1.14
Yield
1.82%
Margin Trading Ratio
4.96
Stock Price
Apr 16, 2026
Opening Apr 16, 9:00 am
4,355 JPY 27.42 USD
Previous Close Apr 15
4,335 JPY 27.27 USD
High Apr 16, 3:30 pm
4,405 JPY 27.75 USD
Low Apr 16, 9:00 am
4,325 JPY 27.23 USD
Volume
85,200
Trading Value
0.37B JPY 2.35M USD
VWAP
4391.04 JPY 27.63 USD
Minimum Trading Value
440,500 JPY 2,772 USD
Market Cap
0.23T JPY 1.44B USD
Number of Trades
302
Liquidity & Number of Trades
As of Apr 16, 2026
Liquidity
Slightly High
1-Year Average
447
1-Year High May 16, 2025
2,469
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 10, 2026 44,900 54,900 1.22
Apr 3, 2026 44,600 68,700 1.54
Mar 27, 2026 49,000 68,600 1.40
Mar 19, 2026 44,900 62,200 1.39
Mar 13, 2026 48,500 56,000 1.15
Company Profile
TOWA PHARMACEUTICAL CO.,LTD. is a leading generic drug manufacturer with strengths in cardiovascular products. The company has expanded from serving clinics to pharmacies and has also entered the healthcare business.
Sector
Pharmaceuticals
TOWA PHARMACEUTICAL CO.,LTD. specializes in the manufacture and sale of prescription drugs, ranking among the top domestic producers of generic medicines, its main product line. The company directly sells its self-manufactured pharmaceuticals to medical institutions, as well as to distributors, pharmaceutical wholesalers, and other manufacturers. Through its group companies, TOWA is also involved in active pharmaceutical ingredient research and production, soft capsule manufacturing, and the planning, development, and contract manufacturing of health foods. Internationally, the company operates generic drug businesses in Europe and the United States through its holding company. Its group companies have research, development, and manufacturing bases in Europe, where they conduct generic drug sales and contract research, development, and manufacturing services.